0
0
Read Time:8 Second
Biocon Limited has informed the Exchange regarding a press release dated July 03, 2025, titled “Advancing Bone Health: European Commission ApprovesBiocon Biologics Denosumab Biosimilars”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
